Bobbi Jo Brockmann's most recent trade in Immucell Corp. was a trade of 18,000 Incentive Stock Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 31, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immucell Corp. | Bobbi Jo Brockmann | Director, VP of Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 18,000 | 0 | - | - | Incentive Stock Options (Right to buy) | |
Immucell Corp. | Bobbi Jo Brockmann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Dec 2020 | 5,258 | - | - | - | Incentive Stock Options (Right to buy) | |
Immucell Corp. | Bobbi Jo Brockmann | Director | Grant, award, or other acquisition of securities at price $ 3.15 per share. | 08 Dec 2020 | 4,742 | 8,521 (0%) | 0% | 3.1 | 14,937 | Common Stock, par value $0.10 per share |